Arcellx (ACLX) News Today $63.75 -1.86 (-2.83%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$63.77 +0.02 (+0.03%) As of 02/21/2025 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Is Arcellx (ACLX) Poised to Capture Significant Market Share?February 20 at 10:21 AM | msn.comArcellx (ACLX) Expected to Announce Quarterly Earnings on WednesdayArcellx (NASDAQ:ACLX) will be releasing earnings before the market opens on Wednesday, February 26.February 19 at 4:28 AM | marketbeat.comShort Interest in Arcellx, Inc. (NASDAQ:ACLX) Grows By 9.1%February 18, 2025 | americanbankingnews.comShort Interest in Arcellx, Inc. (NASDAQ:ACLX) Increases By 9.1%Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) was the recipient of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 7,310,000 shares, a growth of 9.1% from the January 15th total of 6,700,000 shares. Currently, 18.0% of the shares of the stock are sold short. Based on an average daily volume of 615,800 shares, the short-interest ratio is currently 11.9 days.February 16, 2025 | marketbeat.comarcellx director kavita patel sells $96,854 in stockFebruary 5, 2025 | msn.comArcellx, Inc. (NASDAQ:ACLX) Director Sells $96,855.00 in StockArcellx, Inc. (NASDAQ:ACLX - Get Free Report) Director Kavita Patel sold 1,500 shares of the business's stock in a transaction dated Tuesday, February 4th. The shares were sold at an average price of $64.57, for a total transaction of $96,855.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.February 4, 2025 | marketbeat.comArcellx (NASDAQ:ACLX) Trading Down 5.4% - Here's What HappenedArcellx (NASDAQ:ACLX) Trading Down 5.4% - Should You Sell?February 3, 2025 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Short Interest UpdateArcellx, Inc. (NASDAQ:ACLX - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 5,810,000 shares, an increase of 6.6% from the December 31st total of 5,450,000 shares. Currently, 14.3% of the shares of the company are short sold. Based on an average trading volume of 601,000 shares, the days-to-cover ratio is currently 9.7 days.February 2, 2025 | marketbeat.comMoody Aldrich Partners LLC Lowers Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX)Moody Aldrich Partners LLC cut its stake in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 60.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,683 shares of the company's stock after selling 16,122 shares during the quJanuary 30, 2025 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Given Average Rating of "Buy" by BrokeragesShares of Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) have received an average rating of "Buy" from the fifteen analysts that are covering the firm, MarketBeat Ratings reports. Thirteen research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the compaJanuary 30, 2025 | marketbeat.comStifel Nicolaus Remains a Buy on Arcellx Inc (ACLX)January 28, 2025 | markets.businessinsider.comStifel maintains Buy on Arcellx shares, target at $122January 28, 2025 | msn.comCantor Fitzgerald Forecasts Arcellx FY2025 EarningsArcellx, Inc. (NASDAQ:ACLX - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings estimates for Arcellx in a note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Bienkowski anticipates that the company will post earnings of ($2.54) per sJanuary 22, 2025 | marketbeat.comArcellx, Inc.: Trying To Build A Better Myeloma Cell TherapyJanuary 16, 2025 | seekingalpha.comPromising Potential of Arcellx Inc.: Buy Rating Backed by Strong Efficacy in Multiple Myeloma TrialsJanuary 15, 2025 | markets.businessinsider.comArcellx, Inc. (NASDAQ:ACLX) Director Sells $98,805.00 in StockJanuary 15, 2025 | insidertrades.comArcellx, Inc. (NASDAQ:ACLX) Director Kavita Patel Sells 1,500 SharesArcellx, Inc. (NASDAQ:ACLX - Get Free Report) Director Kavita Patel sold 1,500 shares of the stock in a transaction dated Tuesday, January 14th. The stock was sold at an average price of $65.87, for a total transaction of $98,805.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.January 14, 2025 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Insider Sells $261,820.57 in StockArcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 3,553 shares of the firm's stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of $73.69, for a total value of $261,820.57. Following the sale, the insider now owns 25,085 shares in the company, valued at $1,848,513.65. The trade was a 12.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.January 10, 2025 | marketbeat.comJPMorgan Chase & Co. Sells 38,336 Shares of Arcellx, Inc. (NASDAQ:ACLX)JPMorgan Chase & Co. trimmed its position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 13.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 250,123 shares of the company's stock after selling 38,336 sJanuary 9, 2025 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Insider Sells $236,217.37 in StockJanuary 7, 2025 | insidertrades.comPrincipal Financial Group Inc. Has $336,000 Stock Position in Arcellx, Inc. (NASDAQ:ACLX)Principal Financial Group Inc. lessened its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 89.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,018 shares of thJanuary 7, 2025 | marketbeat.comChristopher Heery Sells 3,061 Shares of Arcellx, Inc. (NASDAQ:ACLX) StockArcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 3,061 shares of the stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $77.17, for a total transaction of $236,217.37. Following the completion of the transaction, the insider now directly owns 32,456 shares of the company's stock, valued at approximately $2,504,629.52. The trade was a 8.62 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.January 6, 2025 | marketbeat.comChristopher Heery Sells 3,301 Shares of Arcellx, Inc. (NASDAQ:ACLX) StockArcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 3,301 shares of the company's stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $79.55, for a total value of $262,594.55. Following the completion of the sale, the insider now directly owns 35,517 shares in the company, valued at $2,825,377.35. This trade represents a 8.50 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.January 6, 2025 | marketbeat.comArcellx (NASDAQ:ACLX) Sees Large Volume Increase - Here's What HappenedArcellx (NASDAQ:ACLX) Sees Strong Trading Volume - Should You Buy?January 6, 2025 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Given Average Recommendation of "Buy" by BrokeragesArcellx, Inc. (NASDAQ:ACLX - Get Free Report) has been assigned an average recommendation of "Buy" from the fifteen brokerages that are currently covering the stock, Marketbeat reports. Thirteen research analysts have rated the stock with a buy recommendation and two have issued a strong buy recomJanuary 5, 2025 | marketbeat.comGeode Capital Management LLC Has $81.43 Million Position in Arcellx, Inc. (NASDAQ:ACLX)Geode Capital Management LLC lifted its holdings in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 4.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 974,967 shares of the company's stock after purchasing an additional 39,781 shares during the quarter. GeodeDecember 21, 2024 | marketbeat.comArcellx (NASDAQ:ACLX) Stock Price Down 4.6% - Here's What HappenedArcellx (NASDAQ:ACLX) Trading Down 4.6% - What's Next?December 18, 2024 | marketbeat.comY Intercept Hong Kong Ltd Reduces Position in Arcellx, Inc. (NASDAQ:ACLX)Y Intercept Hong Kong Ltd lowered its position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 75.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,904 shares of the company's stock after selling 11,955December 18, 2024 | marketbeat.comLord Abbett & CO. LLC Has $74.48 Million Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX)Lord Abbett & CO. LLC boosted its stake in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 2.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 891,848 shares of the company's stock after purchasing an additioDecember 15, 2024 | marketbeat.comState Street Corp Has $129.02 Million Holdings in Arcellx, Inc. (NASDAQ:ACLX)State Street Corp lowered its position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 12.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 1,544,939 shares of the company's stock after selling 210,725 shares during the period. State Street Corp owned 2.8December 15, 2024 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Short Interest Up 17.5% in NovemberArcellx, Inc. (NASDAQ:ACLX - Get Free Report) was the recipient of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 5,230,000 shares, an increase of 17.5% from the November 15th total of 4,450,000 shares. Currently, 12.9% of the company's shares are sold short. Based on an average daily volume of 545,200 shares, the days-to-cover ratio is presently 9.6 days.December 14, 2024 | marketbeat.comPromising Outlook for Arcellx Inc: Anito-cel Therapy Positioned as a Safer Alternative with Strong Market PotentialDecember 12, 2024 | markets.businessinsider.comArcellx, Inc. (NASDAQ:ACLX) Receives Average Recommendation of "Buy" from AnalystsShares of Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) have received a consensus recommendation of "Buy" from the fifteen brokerages that are currently covering the stock, MarketBeat reports. Thirteen research analysts have rated the stock with a buy rating and two have given a strong buy rating tDecember 11, 2024 | marketbeat.comArcellx (NASDAQ:ACLX) Given "Buy" Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $115.00 target price on shares of Arcellx in a research report on Tuesday.December 10, 2024 | marketbeat.comArcellx Inc (ACLX) Gets a Buy from Stifel NicolausDecember 9, 2024 | markets.businessinsider.comArcellx Inc (ACLX) Receives a Buy from ScotiabankDecember 9, 2024 | markets.businessinsider.comIn-Depth Examination Of 14 Analyst Recommendations For ArcellxDecember 9, 2024 | benzinga.comNeedham & Company LLC Reiterates Buy Rating for Arcellx (NASDAQ:ACLX)Needham & Company LLC reaffirmed a "buy" rating and set a $105.00 price target on shares of Arcellx in a research note on Monday.December 9, 2024 | marketbeat.comArcellx Announces New Positive Data for Its iMMagine-1 Study in Patients With Relapsed or Refractory Multiple Myeloma to be Presented During an Oral Presentation at the 66th ASH Annual Meeting and ExpositionDecember 8, 2024 | businesswire.comArcellx’s Promising Phase 1 Results and Market Potential for Anito-cel BCMA CAR-T TherapyDecember 6, 2024 | markets.businessinsider.comLeerink Partnrs Analysts Cut Earnings Estimates for ArcellxArcellx, Inc. (NASDAQ:ACLX - Free Report) - Analysts at Leerink Partnrs lowered their FY2024 EPS estimates for Arcellx in a note issued to investors on Wednesday, December 4th. Leerink Partnrs analyst D. Graybosch now anticipates that the company will earn ($1.84) per share for the year, down froDecember 6, 2024 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Stock Holdings Increased by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. increased its stake in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 67.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 79,936 shares of the company's stock after purchasing an additional 32,December 6, 2024 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 8.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 282,855 shares of the compaDecember 6, 2024 | marketbeat.comSamsara BioCapital LLC Has $29.53 Million Stock Position in Arcellx, Inc. (NASDAQ:ACLX)Samsara BioCapital LLC trimmed its position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 22.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 353,641 shares of the company's stock after selling 100,000 shares during the quaDecember 5, 2024 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Shares Purchased by RA Capital Management L.P.RA Capital Management L.P. boosted its position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 15.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,851,479 shares of the company's stock after acquiring an additional 2December 5, 2024 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Holdings Boosted by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company grew its stake in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 15.7% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 84,839 shares of the coDecember 5, 2024 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Shares Bought by Citigroup Inc.Citigroup Inc. boosted its holdings in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 97.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,154 shares of the company's stock after purchasing an additional 21,262 shares duringDecember 5, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 14,200 Shares of Arcellx, Inc. (NASDAQ:ACLX)Charles Schwab Investment Management Inc. raised its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 4.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 328,093 shares of the company's stockDecember 5, 2024 | marketbeat.comParkman Healthcare Partners LLC Lowers Holdings in Arcellx, Inc. (NASDAQ:ACLX)Parkman Healthcare Partners LLC trimmed its position in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 57.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 66,492 shares of the company's stock after selling 90,351 shares during the quarter. ParkDecember 4, 2024 | marketbeat.comArcellx, Inc. (NASDAQ:ACLX) Shares Acquired by Janus Henderson Group PLCJanus Henderson Group PLC boosted its holdings in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 5.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,011,950 shares of the company's stock after acquiring anDecember 4, 2024 | marketbeat.com Get Arcellx News Delivered to You Automatically Sign up to receive the latest news and ratings for ACLX and its competitors with MarketBeat's FREE daily newsletter. Email Address ACLX Media Mentions By Week ACLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACLX News Sentiment▼0.960.60▲Average Medical News Sentiment ACLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACLX Articles This Week▼45▲ACLX Articles Average Week Get Arcellx News Delivered to You Automatically Sign up to receive the latest news and ratings for ACLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GMAB News Today ITCI News Today VTRS News Today MRNA News Today RDY News Today PCVX News Today SRPT News Today QGEN News Today ASND News Today ROIV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACLX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcellx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcellx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
